172 related articles for article (PubMed ID: 38728519)
1. Exploring the interconnected between type 2 diabetes mellitus and nonalcoholic fatty liver disease: Genetic correlation and Mendelian randomization analysis.
Ni W; Lu Y; Wang W
Medicine (Baltimore); 2024 May; 103(19):e38008. PubMed ID: 38728519
[TBL] [Abstract][Full Text] [Related]
2. Nonalcoholic fatty liver disease and type 2 diabetes: an observational and Mendelian randomization study.
Yu Y; Yu Y; Wang Y; Chen Y; Wang N; Wang B; Lu Y
Front Endocrinol (Lausanne); 2023; 14():1156381. PubMed ID: 37223039
[TBL] [Abstract][Full Text] [Related]
3. A comprehensive gene-centric pleiotropic association analysis for 14 psychiatric disorders with GWAS summary statistics.
Lu H; Qiao J; Shao Z; Wang T; Huang S; Zeng P
BMC Med; 2021 Dec; 19(1):314. PubMed ID: 34895209
[TBL] [Abstract][Full Text] [Related]
4. Association between nonalcoholic fatty liver disease and type 2 diabetes: A bidirectional two-sample mendelian randomization study.
Ni X; Tong C; Halengbieke A; Cao T; Tang J; Tao L; Zheng D; Han Y; Li Q; Yang X
Diabetes Res Clin Pract; 2023 Dec; 206():110993. PubMed ID: 37931882
[TBL] [Abstract][Full Text] [Related]
5. Type 1 diabetes mellitus and non-alcoholic fatty liver disease: a two-sample Mendelian randomization study.
Tuo L; Yan LT; Liu Y; Yang XX
Front Endocrinol (Lausanne); 2024; 15():1315046. PubMed ID: 38681765
[TBL] [Abstract][Full Text] [Related]
6. Identification of shared genetic architecture between non-alcoholic fatty liver disease and type 2 diabetes: A genome-wide analysis.
Tan Y; He Q; Chan KHK
Front Endocrinol (Lausanne); 2023; 14():1050049. PubMed ID: 37033223
[TBL] [Abstract][Full Text] [Related]
7. Shared genetic links between hypothyroidism and psychiatric disorders: evidence from a comprehensive genetic analysis.
Zhou J; Zhu L
Front Endocrinol (Lausanne); 2024; 15():1370019. PubMed ID: 38904036
[TBL] [Abstract][Full Text] [Related]
8. Proteome-wide Mendelian randomization identifies potential therapeutic targets for nonalcoholic fatty liver diseases.
Li J; Ma X; Yin C
Sci Rep; 2024 May; 14(1):11814. PubMed ID: 38782984
[TBL] [Abstract][Full Text] [Related]
9. Habitual coffee intake and risk for nonalcoholic fatty liver disease: a two-sample Mendelian randomization study.
Zhang Y; Liu Z; Choudhury T; Cornelis MC; Liu W
Eur J Nutr; 2021 Jun; 60(4):1761-1767. PubMed ID: 32856188
[TBL] [Abstract][Full Text] [Related]
10. Identification of novel variants associated with osteoporosis, type 2 diabetes and potentially pleiotropic loci using pleiotropic cFDR method.
Hu Y; Tan LJ; Chen XD; Greenbaum J; Deng HW
Bone; 2018 Dec; 117():6-14. PubMed ID: 30172742
[TBL] [Abstract][Full Text] [Related]
11. Non-alcoholic fatty liver disease and complications in type 1 and type 2 diabetes: A Mendelian randomization study.
Liu N; Wang G; Liu C; Liu J; Huang S; Zhou Y; Xiao E
Diabetes Obes Metab; 2023 Feb; 25(2):365-376. PubMed ID: 36181433
[TBL] [Abstract][Full Text] [Related]
12. Evaluating the role of non-alcoholic fatty liver disease in cardiovascular diseases and type 2 diabetes: a Mendelian randomization study in Europeans and East Asians.
Au Yeung SL; Borges MC; Wong THT; Lawlor DA; Schooling CM
Int J Epidemiol; 2023 Jun; 52(3):921-931. PubMed ID: 36367831
[TBL] [Abstract][Full Text] [Related]
13. Lifestyle and metabolic factors for nonalcoholic fatty liver disease: Mendelian randomization study.
Yuan S; Chen J; Li X; Fan R; Arsenault B; Gill D; Giovannucci EL; Zheng JS; Larsson SC
Eur J Epidemiol; 2022 Jul; 37(7):723-733. PubMed ID: 35488966
[TBL] [Abstract][Full Text] [Related]
14. Genetic effects and causal association analyses of 14 common conditions/diseases in multimorbidity patterns.
Fu T; Yang YQ; Tang CH; He P; Lei SF
PLoS One; 2024; 19(5):e0300740. PubMed ID: 38753827
[TBL] [Abstract][Full Text] [Related]
15. Evaluating the distinct pleiotropic effects of omega-3 fatty acids on type 2 diabetes mellitus: a mendelian randomization study.
Hu C; Zhou Y; Wu X; Jia X; Zhu Y; Zheng R; Wang S; Lin L; Qi H; Lin H; Li M; Wang T; Zhao Z; Xu M; Xu Y; Chen Y; Ning G; Borges MC; Wang W; Zheng J; Bi Y; Lu J
J Transl Med; 2023 Jun; 21(1):370. PubMed ID: 37286992
[TBL] [Abstract][Full Text] [Related]
16. Blood Levels of the
Ghodsian N; Gagnon E; Bourgault J; Gobeil É; Manikpurage HD; Perrot N; Girard A; Mitchell PL; Arsenault BJ
Nutrients; 2021 Nov; 13(12):. PubMed ID: 34959760
[TBL] [Abstract][Full Text] [Related]
17. Causal effects from non-alcoholic fatty liver disease on kidney function: A Mendelian randomization study.
Park S; Lee S; Kim Y; Cho S; Kim K; Chul Kim Y; Han SS; Lee H; Lee JP; Joo KW; Lim CS; Kim YS; Kim DK
Liver Int; 2022 Feb; 42(2):412-418. PubMed ID: 34843158
[TBL] [Abstract][Full Text] [Related]
18. Serum Uric Acid Levels and Nonalcoholic Fatty Liver Disease: A 2-Sample Bidirectional Mendelian Randomization Study.
Li S; Fu Y; Liu Y; Zhang X; Li H; Tian L; Zhuo L; Liu M; Cui J
J Clin Endocrinol Metab; 2022 Jul; 107(8):e3497-e3503. PubMed ID: 35363278
[TBL] [Abstract][Full Text] [Related]
19. Genetic association of lipids and lipid-lowering drug target genes with non-alcoholic fatty liver disease.
Li Z; Zhang B; Liu Q; Tao Z; Ding L; Guo B; Zhang E; Zhang H; Meng Z; Guo S; Chen Y; Peng J; Li J; Wang C; Huang Y; Xu H; Wu Y
EBioMedicine; 2023 Apr; 90():104543. PubMed ID: 37002989
[TBL] [Abstract][Full Text] [Related]
20. Homocysteine, folate, and nonalcoholic fatty liver disease: a systematic review with meta-analysis and Mendelian randomization investigation.
Yuan S; Chen J; Dan L; Xie Y; Sun Y; Li X; Larsson SC
Am J Clin Nutr; 2022 Dec; 116(6):1595-1609. PubMed ID: 36205540
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
